Sundaram Multi Pap Q3FY26 Standalone Results: Profit ₹161.99 Lacs, Revenue ₹2,606.83 Lacs
Sundaram Multi Pap reported Q3FY26 profit of ₹161.99 lacs on revenue of ₹2,606.83 lacs. For the nine months, profit was ₹200.62 lacs. The results were approved by the board on February 14, 2026. Previously, shareholders approved a preferential issue of 7.04 crore equity shares.
The improved financial performance is a positive development for the company. The ongoing preferential issue also indicates corporate action that could impact the company's structure and future performance, warranting a medium impact assessment.
The company has reported a profitable quarter after a loss in the previous year, and a significant improvement in profit for the nine-month period. This turnaround indicates positive financial performance.
Sundaram Multi Pap Limited announced its unaudited standalone financial results for the quarter and nine months ended December 31, 2025. The company reported a profit after tax of ₹161.99 lacs for the quarter, compared to a loss of ₹268.53 lacs in the same period last year. Revenue from operations for the quarter stood at ₹2,606.83 lacs, an increase from ₹2,135.53 lacs in the corresponding quarter of the previous year.
For the nine-month period ended December 31, 2025, the company posted a profit after tax of ₹200.62 lacs, a significant improvement from a loss of ₹426.81 lacs in the same period last fiscal. Total income for the nine months was ₹9,368.81 lacs.
The Board of Directors approved these results in a meeting held on February 14, 2026, which commenced at 11:00 AM and concluded at 02:00 PM at the company's Mumbai office. The limited review report on these financial results was also issued.
Additionally, the company noted that shareholders had approved the issuance of 7,04,00,000 Equity Shares on a preferential basis to Sundaram Land and Assets Private Limited during an Extra Ordinary General Meeting on November 12, 2025. This is part of the acquisition of 52.38% shareholding in the target company.
What to do with a filing like this
Sundaram Multi Pap Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Sundaram Multi Pap Limited. Read the original for the full detail.